Date

Tuesday, March 14, 2023

Venue

Plaza Mandiri Auditorium fl. 3 Plaza Mandiri,
Jend. Gatot Subroto St Lot. 36-38,
Jakarta 12190

Time

14:00 (GMT+7)

 Agenda

  1. Approval of the Annual Report and Ratification of the company's Consolidated Financial Statements, Approval of the Board of Commissioners Oversight Report; and Ratification of the Financial Report of the Micro and Small Business Funding Program (PUMK) for the financial year 2022; and to release and discharge of all responsibilities (volledig acquit et de charge) to all Board members for the management and supervision carried out in the financial year 2021.
  2. Approval on the use of the company's Net Profit for the financial year 2022.
  3. Determination of remuneration (salary/honorarium, facilities and allowances) for 2023 and Tantiem of the financial year 2022 for Directors and Board of Commissioners.
  4. Appointment of a Public Accountant and/or Public Accounting Firm (KAP) to audit the company's Consolidated Financial Statements and the Financial Statements of the Micro and Small Business Funding Program (PUMK) for the financial year 2023.
  5. Approval of the company's Resolution Plan.
  6. Approval of the company's Stock Split with a ratio of 1:2 or from Rp 250.00 (two hundred fifty rupiah) per share to Rp 125.00 (one hundred twenty five rupiah) per share.
  7. Approval of amendments to the company's Articles of Association.
  8. Changes in the company's management composition.

DH/W

BMRI - PT. Bank Mandiri (Persero) Tbk

Rp 6.750

-200 (-3,00%)